🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Michael Farrell

IULM University

ORCID: 0000-0001-7008-8130

Also affiliated with Botsford Hospital, Nova Scotia Health Authority, UNSW Sydney, Beaumont Hospital, Dearborn, National Centre for Clinical Research on Emerging Drugs, California State University, Sacramento

MedicinePharmacology, Toxicology and Pharmaceutics

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 6%percentile
0.241Author DataRank

Indexed papers

2in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Data Resource Profile Update: The Opioid Agonist Treatment and Safety II (OATS II) Study, 2001–22, New South Wales, Australia

International Journal of Epidemiology(2025)10.1093/ije/dyaf037
Top 61%
0.241DataRank
Top 61%4 citations

Fathima Nimnaz Ghouse, Amy Gibson, Duong Thuy Tran, Thomas Santo, Chrianna Bharat +3 more

Papers

Driven by 18 papers — median percentile 39. Top paper: “Outcomes of a single-arm implementation trial of extended-release subcutaneous buprenorphine depot injections in people with opioid dependence”.

Outcomes of a single-arm implementation trial of extended-release subcutaneous buprenorphine depot injections in people with opioid dependence

International Journal of Drug Policy(2021)10.1016/j.drugpo.2021.103492
N/A
2.1DataRank · unranked
52 citations

Jeyran Shahbazi, Marianne Byrne, Jason Grebely, Nicholas Lintzeris, Mark S. Chambers +13 more

Infant High-Grade Gliomas Comprise Multiple Subgroups Characterized by Novel Targetable Gene Fusions and Favorable Outcomes

Cancer Discovery(2020)10.1158/2159-8290.cd-19-1030
N/A
0.846DataRank · unranked
280 citations

Alan Mackay, Britta Ismer, Jessica C. Pickles, Ruth G. Tatevossian, Scott Newman +95 more

96-week retention in treatment with extended-release subcutaneous buprenorphine depot injections among people with opioid dependence: Extended follow-up after a single-arm trial

International Journal of Drug Policy(2024)10.1016/j.drugpo.2024.104390
N/A
0.730DataRank · unranked
21 citations

Jeyran Shahbazi, Mark S. Chambers, Marianne Byrne, Jaleh Gholami, Emma Zahra +14 more

Tinkering with care: Implementing extended-release buprenorphine depot treatment for opioid dependence

International Journal of Drug Policy(2024)10.1016/j.drugpo.2024.104359
N/A
0.616DataRank · unranked
15 citations

Sandra Gendera, Carla Treloar, Tim Rhodes, Jeyran Shahbazi, Marianne Byrne +4 more

Integrating HIV pre‐exposure prophylaxis and harm reduction among men who have sex with men and transgender women to address intersecting harms associated with stimulant use: a modelling study

Journal of the International AIDS Society(2020)10.1002/jia2.25495
N/A
0.500DataRank · unranked
27 citations

Katherine M. Rich, Michael Farrell, Louisa Degenhardt, Rebecca McKetin, Lucy Thi Tran +8 more

Pharmaceutical Opioid Use Patterns and Indicators of Extramedical Use and Harm in Adults With Chronic Noncancer Pain, 2012-2018

JAMA Network Open(2021)10.1001/jamanetworkopen.2021.3059
N/A
0.345DataRank · unranked
9 citations

Phillip Hungerford, Suzanne Nielsen, Raimondo Bruno, Briony Larance, Philip Clare +8 more

Quantifying the impact of a large‐scale opioid agonist treatment program on suicide prevention in New South Wales, Australia: A data‐modeling study

Addiction(2025)10.1111/add.70018
N/A
0.241DataRank · unranked
4 citations

Antoine Chaillon, Natasha K. Martin, Matthew Hickman, N. R. Jones, Michael Farrell +4 more

Data Resource Profile Update: The Opioid Agonist Treatment and Safety II (OATS II) Study, 2001–22, New South Wales, Australia

International Journal of Epidemiology(2025)10.1093/ije/dyaf037
Top 61%
0.241DataRank
Top 61%4 citations

Fathima Nimnaz Ghouse, Amy Gibson, Duong Thuy Tran, Thomas Santo, Chrianna Bharat +3 more

The impact of a voluntary alcohol and other drug diversion program on reoffending, imprisonment, and health

International Journal of Drug Policy(2025)10.1016/j.drugpo.2025.104747
N/A
0.104DataRank · unranked
1 citations

Sara Rahman, Stephanie Todd, Suzanne Poynton, Samantha Black, Tanya Merinda +2 more

Opioid agonist treatment and risk of death or rehospitalization following injection drug use–associated bacterial and fungal infections: A cohort study in New South Wales, Australia

PLoS Medicine(2022)10.1371/journal.pmed.1004049
N/A
0DataRank · unranked
21 citations

Dan Lewer, N. R. Jones, Samantha Colledge‐Frisby, Michael Farrell, Matthew Hickman +4 more

Examining the cost and impact of dosing fees among clients in opioid agonist treatment: Results from a cross‐sectional survey of Australian treatment clients

Drug and Alcohol Review(2022)10.1111/dar.13437
N/A
0DataRank · unranked
12 citations

Rory Chen, Suzanne Nielsen, Anh Tran, Thomas Santo, Louisa Degenhardt +5 more

Incidence of suicide and self-harm among people with opioid use disorder and the impact of opioid agonist treatment: A retrospective data linkage study

Drug and Alcohol Dependence(2023)10.1016/j.drugalcdep.2023.109851
N/A
0DataRank · unranked
16 citations

N. R. Jones, Louisa Degenhardt, Matthew Hickman, Prianka Padmanathan, Thomas Santo +3 more

The prevalence of gambling and problematic gambling: a systematic review and meta-analysis

The Lancet Public Health(2024)10.1016/s2468-2667(24)00126-9
N/A
0DataRank · unranked
228 citations

Heather Wardle, Samantha Colledge‐Frisby, Sophia Taylor, Michelle Lynch, Jürgen Rehm +7 more

Botulinum Toxin A for Chronic Exertional Compartment Syndrome Evaluated With Shear Wave Elastography: A Case Report

Clinical Journal of Sport Medicine(2021)10.1097/jsm.0000000000000910
N/A
0DataRank · unranked
5 citations

Jordan Wickstrom, Michael Farrell, Katharine Alter, William A. Berrigan

Modeling the population‐level impact of opioid agonist treatment on mortality among people accessing treatment between 2001 and 2020 in New South Wales, Australia

Addiction(2021)10.1111/add.15736
N/A
0DataRank · unranked
29 citations

Chrianna Bharat, Jack Stone, Nicola Jones, Louisa Degenhardt, Sarah Larney +6 more

Fatal opioid overdoses during and shortly after hospital admissions in England: A case-crossover study

PLoS Medicine(2021)10.1371/journal.pmed.1003759
N/A
0DataRank · unranked
51 citations

Brian J. Eastwood, Martin White, Thomas D. Brothers, Martin McCusker, Caroline S. Copeland +3 more

Association of Opioid Agonist Treatment With All-Cause Mortality and Specific Causes of Death Among People With Opioid Dependence

JAMA Psychiatry(2021)10.1001/jamapsychiatry.2021.0976
N/A
0DataRank · unranked
589 citations

Brodie Clark, Matthew Hickman, Jason Grebely, Gabrielle Campbell, Luis Sordo +14 more

Retention of opioid agonist treatment prescribers across New South Wales, Australia, 2001–2018: Implications for treatment systems and potential impact on client outcomes

Drug and Alcohol Dependence(2020)10.1016/j.drugalcdep.2020.108464
N/A
0DataRank · unranked
27 citations

Suzanne Nielsen, Michael Farrell, Robert Ali, Anthony J. Gill, Sarah Larney +2 more